SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ECAT

BlackRock ESG Capital Allocation Term Trust (New York Stock Exchange:ECAT)

US · Delayed Price · Currency is USD
Financial Services · Asset Management
13.16+0.05 (+0.38%)
 
Market cap
$1.31B
Health Score
Listed since
Sep 28, 2021
Insider Score
––Not scored
ECAT Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

Financial Health Score
Strong
From ECAT’s reported statements · FY2025
Profitability20 / 20

Keeps a healthy share of every dollar it sells.

Revenue
$216.2M
Net income
$213.4M
Net margin
98.7%
Leverage20 / 20

Little or no net debt.

Total debt
$382K
Cash
$3.3M
Net debt / EBITDA
-0.01x
Liquidity0 / 20

Owes more within a year than it holds to pay it.

Current assets
$3.3M
Current liabilities
$151.6M
Current ratio
0.02
Cash generation20 / 20

The business funds itself from operations.

Operating cash flow
$344.6M
Free cash flow
$344.6M
FCF margin
159.4%
Dilution & runway20 / 20

Not funding itself by issuing shares.

Shares outstanding
101.5M
Share growth (1y)
0.0%

Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.

ECAT Income Statement

No quarterly statements available for ECAT.

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.